In vitro methods for hazard assessment of industrial chemicals - Opportunities and challenges

Frontiers in Pharmacology

Volumn 6, Issue MAY, 2015, Pages

  Wong, Chin Lin ^a   Ghassabian, Sussan ^a   Smith, Maree T ^a   Lam, Ai Leen ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Allergic contact dermatitis; Epoxy resins; In vitro methods; Integrated hazard classification; Skin sensitization

Indexed keywords

ALLERGEN; CONTACT ALLERGEN; COSMETIC; EPOXY RESIN; INDUSTRIAL CHEMICAL;

DELAYED HYPERSENSITIVITY; EXPOSURE; HAZARD ASSESSMENT; HIGH THROUGHPUT SCREENING; HUMAN; IN VITRO STUDY; LOCAL LYMPH NODE ASSAY; NONHUMAN; OCCUPATIONAL HAZARD; OCCUPATIONAL SKIN DISEASE; PREDICTION; REVIEW; SKIN ALLERGY; SKIN SENSITIZATION; T LYMPHOCYTE; WORKPLACE;

EID: 84930671495     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2015.00094     Document Type: Review

References (99)

1. Ade, N., Martinozzi-Teissier, S., Pallardy, M., and Rousset, F. (2006). Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J. Immunol. 3, 189-197. doi: 10.1080/15476910600978038.
2. Aeby, P., Ashikaga, T., Bessou-Touya, S., Schepky, A., Gerberick, F., Kern, P., et al. (2010). Identifying and characterizing chemical skin sensitizers without animal testing: Colipa's research and method development program. Toxicol. In Vitro 24, 1465-1473. doi: 10.1016/j.tiv.2010.07.005.
3. Albrekt, A. S., Johansson, H., Borje, A., Borrebaeck, C., and Lindstedt, M. (2014). Skin sensitizers differentially regulate signaling pathways in MUTZ-3 cells in relation to their individual potency. BMC Pharmacol. Toxicol. 15:5. doi: 10.1186/2050-6511-15-5.
4. Aleksic, M., Pease, C. K., Basketter, D. A., Panico, M., Morris, H. R., and Dell, A. (2007). Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicol. In Vitro 21, 723-733. doi: 10.1016/j.tiv.2007.01.008.
5. Amado, A., and Taylor, J. S. (2008). Contact allergy to epoxy resins. Contact Dermat. 58, 186-187. doi: 10.1111/j.1600-0536.2007.01245.x.
6. Anderson, S. E., Siegel, P. D., and Meade, B. J. (2011). The LLNA: a brief review of recent advances and limitations. J. Allergy 2011, 424203. doi: 10.1155/2011/424203.
7. Ashikaga, T., Yoshida, Y., Hirota, M., Yoneyama, K., Itagaki, H., Sakaguchi, H., et al. (2006). Development of an in vitro skin sensitization test using human cell lines: the human cell line activation test (h-CLAT) I. Optimization of the h-CLAT protocol. Toxicol. In Vitro 20, 767-773. doi: 10.1016/j.tiv.2005.10.012.
8. Bangsgaard, N., Thyssen, J. P., Menne, T., Andersen, K. E., Mortz, C. G., Paulsen, E., et al. (2012). Contact allergy to epoxy resin: risk occupations and consequences. Contact Dermat. 67, 73-77. doi: 10.1111/j.1600-0536.2012.02072.x.
9. Basketter, D. A. (2009). The human repeated insult patch test in the 21st century: a commentary. Cutan. Ocul. Toxicol. 28, 49-53. doi: 10.1080/15569520902938032.
10. Basketter, D., and Maxwell, G. (2007). In vitro approaches to the identification and characterization of skin sensitizers. Cutan. Ocul. Toxicol. 26, 359-373. doi: 10.1080/15569520701622993.
11. Bauch, C., Kolle, S. N., Ramirez, T., Eltze, T., Fabian, E., Mehling, A., et al. (2012). Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul. Toxicol. Pharm. 63, 489-504. doi: 10.1016/j.yrtph.2012.05.013.
12. Beliauskiene, A., Valiukeviciene, S., Uter, W., and Schnuch, A. (2011). The European baseline series in Lithuania: results of patch testing in consecutive adult patients. J. Eur. Acad. Dermatol. Venereol. 25, 59-63. doi: 10.1111/j.1468-3083.2010.03688.x.
13. Belsito, D. V. (2005). Occupational contact dermatitis: etiology, prevalence, and resultant impairment/disability. J. Am. Acad. Dermatol. 53, 303-313. doi: 10.1016/j.jaad.2005.02.045.
14. Bergström, M. A., Ott, H., Carlsson, A., Neis, M., Zwadlo-Klarwasser, G., Jonsson, C. A. M., et al. (2007). A skin-like cytochrome P450 cocktail activates prohaptens to contact allergenic metabolites. J. Invest. Dermatol. 127, 1145-1153. doi: 10.1038/Sj. Jid.5700638.
15. Björkner, B., Frick-Engfeldt, M., Pontén, A., and Zimerson, E. (2011). "Plastic materials, "in Contact Dermatitis, eds J. D. Johansen, P. J. Frosch, and J.-P. Lepoittevin (Berlin: Springer), 695-728. doi: 10.1007/978-3-642-03827-3_37.
16. Broughton, W. E. (1965). Epoxy resins in industry: the hazards and their control. Ann. Occup. Hyg. 8, 131-142. doi: 10.1093/annhyg/8.2.131.
17. Cahill, J., Keegel, T., Dharmage, S., Nugriaty, D., and Nixon, R. (2005). Prognosis of contact dermatitis in epoxy resin workers. Contact Dermat. 52, 147-153. doi: 10.1111/j.0105-1873.2005.00542.x.
18. Cahill, J., Williams, J. D. L., Matheson, M. C., Palmer, A. M., Burgess, J. A., Dharmage, S. C., et al. (2012). Occupational Contact Dermatitis: a Review of 18 Years of Data from an Occupational Dermatology Clinic in Australia. Research Reports. Canberra: Safe Work Australia.
19. Canelas, M. M., Goncalo, M., and Figueiredo, A. (2010). Contact allergy to epoxy resins-a 10-year study. Contact Dermat. 62, 55. doi: 10.1111/j.1600-0536.2009.01652.x.
20. Carlson, R. V., Boyd, K. M., and Webb, D. J. (2004). The revision of the Declaration of Helsinki: past, present and future. Brit. J. Clin. Pharm. 57, 695-713. doi: 10.1111/J.1365-2125.2004.02103.X.
21. Cashman, M. W., Reutemann, P. A., and Ehrlich, A. (2012). Contact dermatitis in the United States: Epidemiology, economic impact, and workplace prevention. Dermatol. Clin. 30, 87-98. doi: 10.1016/j.det.2011.08.004.
22. Cheng, S. W., Cao, M., Zhang, Y. L., Peng, S. G., Dong, J., Zhang, D., et al. (2011). Time trends of contact allergy to amodified European baseline series in Beijing between 2001 and 2006. Contact Dermat. 65, 22-27. doi: 10.1111/j.1600-0536.2011.01897.x.
23. Chipinda, I., Hettick, J. M., and Siegel, P. D. (2011). Haptenation: chemical reactivity and protein binding. J. Allergy 2011, 839682. doi: 10.1155/2011/839682.
24. Coutant, K. D., De Fraissinette, A. D., Cordier, A., and Ulrich, P. (1999). Modulation of the activity of human monocyte-derived dendritic cells by chemical haptens, a metal allergen, and a staphylococcal superantigen. Toxicol. Sci. 52, 189-198. doi: 10.1093/toxsci/52.2.189.
25. Delaine, T., Niklasson, I. B., Emter, R., Luthman, K., Karlberg, A. T., and Natsch, A. (2011). Structure-activity relationship between the in vivo skin sensitizing potency of analogues of phenyl glycidyl ether and the induction of Nrf2-dependent luciferase activity in the KeratinoSens in vitro assay. Chem. Res. Toxicol. 24, 1312-1318. doi: 10.1021/Tx200196s.
26. Dietrich, J., and Mirasol, F. (2012). Epoxy resins. ICIS Chemical Business, 23 Jan 2012. Available at: http://www.icis.com/resources/news/2012/01/23/9525472/chemical-profile-epoxy-resins/(accessed June 4, 2013).
27. Dietz, L., Esser, P. R., Schmucker, S. S., Goette, I., Richter, A., Schnolzer, M., et al. (2010). Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol. Sci. 117, 336-347. doi: 10.1093/toxsci/kfq209.
28. Dietz, L., Kinzebach, S., Ohnesorge, S., Franke, B., Goette, I., Koenig-Gressel, D., et al. (2013). Proteomic allergen-peptide/protein interaction assay for the identification of human skin sensitizers. Toxicol. In Vitro 27, 1157-1162. doi: 10.1016/j.tiv.2012.08.013.
29. ECVAM. (2014). EURL ECVAM Recommendation on the KeratinoSensTM Assay for Skin Sensitisation Testing. Available at: http://ihcp.jrc.ec.europa.eu/our_labs/eurl-ecvam/eurl-ecvam-recommendations/recommendation-keratinosens-skin-sensitisation [accessed February 19, 2015].
30. Emter, R., Ellis, G., and Natsch, A. (2010). Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharm. 245, 281-290. doi: 10.1016/j.taap.2010.03.009.
31. Evers, P. (2013). Skin Disease Treatment Technologies and Global Markets. Available at: http://www.bccresearch.com/market-research/pharmaceuticals/skin-diseases-dermatology-market-phm127a.html [accessed February 18, 2015].
32. Flecknell, P. A. (2002). Replacement, reduction and refinement. Altern. Anim. Ex. 19, 47-53.
33. Galvao, J., Davis, B., Tilley, M., Normando, E., Duchen, M. R., and Cordeiro, M. F. (2014). Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J. 28, 1317-1330. doi: 10.1096/Fj.13-235440.
34. Gamer, A. O., Nies, E., and Vohr, H. W. (2008). Local lymph node assay (LLNA): comparison of different protocols by testing skin-sensitizing epoxy resin system components. Regul. Toxicol. Pharm. 52, 290-298. doi: 10.1016/j.yrtph.2008.08.018.
35. Geier, J., Lessmann, H., Hillen, U., Jappe, U., Dickel, H., Koch, P., et al. (2004). An attempt to improve diagnostics of contact allergy due to epoxy resin systems. First results of the multicentre study EPOX 2002. Contact Dermat. 51, 263-272. doi: 10.1111/J.0105-1873.2004.00465.X.
36. Geraut, C., Tripodi, D., Brunet-Courtois, B., Leray, F., and Geraut, L. (2009). Occupational dermatitis to epoxydic and phenolic resins. Eur. J. Dermatol. 19, 205-213. doi: 10.1684/Ejd.2009.0666.
37. Gerberick, G. F., Vassallo, J. D., Bailey, R. E., Chaney, J. G., Morrall, S. W., and Lepoittevin, J. P. (2004). Development of a peptide reactivity assay for screening contact allergens. Toxicol. Sci. 81, 332-343. doi: 10.1093/toxsci/kfh213.
38. Gerberick, G. F., Vassallo, J. D., Foertsch, L. M., Price, B. B., Chaney, J. G., and Lepoittevin, J.-P. (2007). Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol. Sci. 97, 417-427. doi: 10.1093/toxsci/kfm064.
39. GIA forecasts the global market. (2012). GIA forecasts the global market for epoxy resins to reach 3.03 million tons by 2017 (Market Reports). Coatings World. Available at: http://www.coatingsworld.com/issues/2012-04/view_market-research/gia-s-report-forecasts-the-global-market-for-epoxy/[accessed May 31, 2013].
40. Gibbs, S., Van De Sandt, J. J. M., Merk, H. F., Lockley, D. J., Pendlington, R. U., and Pease, C. K. (2007). Xenobiotic metabolism in human skin and 3D human skin reconstructs: a review. Curr. Drug Metab. 8, 758-772. doi: 10.2174/138920007782798225.
41. Gimenez-Arnau, A. M. (2011). "Occupational contact dermatitis: health personnel, "in Contact Dermatitis, 5th Edn, eds J. D. Johansen, P. J. Frosch, and J.-P. Lepoittevin (Berlin Heidelberg: Springer-Verlag), 841-851. doi: 10.1007/978-3-642-03827-3_43.
42. Hu, Z. B., Ma, W., Zaborski, M., Macleod, R. a. F., Quentmeier, H., and Drexler, H. G. (1996). Establishment and characterization of two novel cytokine-responsive acute myeloid and monocytic leukemia cell lines, MUTZ-2 and MUTZ-3. Leukemia 10, 1025-1040.
43. Jaworska, J., Harol, A., Kern, P. S., and Gerberick, G. F. (2011). Integrating non-animal test information into an adaptive testing strategy-skin sensitization proof of concept case. Altern. Anim. Ex. 28, 211-225. doi: 10.14573/altex.2011.3.211.
44. Johansson, H., Albrekt, A. S., Borrebaeck, C. A. K., and Lindstedt, M. (2013). The GARD assay for assessment of chemical skin sensitizers. Toxicol. In Vitro 27, 1163-1169. doi: 10.1016/j.tiv.2012.05.019.
45. Johansson, H., Lindstedt, M., Albrekt, A. S., and Borrebaeck, C. A. K. (2011). A genomic biomarker signature can predict skin sensitizers using a cell-based in vitro alternative to animal tests. BMC Genomics 12:399. doi: 10.1186/1471-2164-12-399.
46. Jolanki, R., Estlander, T., and Kanerva, L. (2001). 182 patients with occupational allergic epoxy contact dermatitis over 22 years. Contact Dermat. 44, 121-123. doi: 10.1034/j.1600-0536.2001.44020920.x.
47. Jowsey, I. R., Basketter, D. A., Westmoreland, C., and Kimber, I. (2006). A future approach to measuring relative skin sensitising potency: a proposal. J. Appl. Toxicol. 26, 341-350. doi: 10.1002/Jat.1146.
48. Kaplan, D. H., Igyarto, B. Z., and Gaspari, A. A. (2012). Early immune events in the induction of allergic contact dermatitis. Nat. Rev. Immunol. 12, 114-124. doi: 10.1038/Nri3150.
49. Kimber, I., Basketter, D. A., Butler, M., Gamer, A., Garrigue, J. L., Gerberick, G. F., et al. (2003). Classification of contact allergens according to potency: proposals. Food Chem. Toxicol. 41, 1799-1809. doi: 10.1016/S0278-6915(03)00223-0.
50. Kimber, I., Basketter, D. A., Gerberick, G. F., and Dearman, R. J. (2002a). Allergic contact dermatitis. Int. Immunopharmacol. 2, 201-211. doi: 10.1016/S1567-5769(01)00173-4.
51. Kimber, I., Dearman, R. J., Basketter, D. A., Ryan, C. A., and Gerberick, G. F. (2002b). The local lymph node assay: past, present and future. Contact Dermat. 47, 31-328. doi: 10.1034/j.1600-0536.2002.470601.x.
52. Kimber, I., Basketter, D. A., Gerberick, G. F., Ryan, C. A., and Dearman, R. J. (2011). Chemical allergy: translating biology into hazard characterization. Toxicol. Sci. 120, S238-S268. doi: 10.1093/toxsci/kfq346.
53. Koss, A., Lucero, G., and Koziner, B. (1996). Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor and interleukin 4 induce differentiation in the U-937 human monocytic leukemia cell line. Leukemia Lymphoma 22, 163-171. doi: 10.3109/10428199609051744.
54. Lalko, J. F., Kimber, I., Gerberick, G. F., Foertsch, L. M., Api, A. M., and Dearman, R. J. (2012). The direct peptide teactivity assay: selectivity of chemical respiratory allergens. Toxicol. Sci. 129, 421-431. doi: 10.1093/toxsci/kfs205.
55. Landsteiner, K., and Jacobs, J. (1935). Studies on the sensitization of animals with simple chemical compounds. J. Exp. Med. 61, 643-656. doi: 10.1084/jem.61.5.643.
56. Li, D., Han, Y., Meng, X., Sun, X., Yu, Q., Li, Y., et al. (2010). Effect of regular organic solvents on cytochrome P450-mediated metabolic activities in rat liver microsomes. Drug Metab. Dispos. 38, 1922-1925. doi: 10.1124/dmd.110.033894.
57. Lowney, A., and Bourke, J. F. (2011). A study of occupational contact dermatitis in the pharmaceutical industry. Brit. J. Dermatol. 165, 73.
58. Lushniak, B. D. (2000). Occupational skin diseases. Prim. Care 27, 895-915. doi: 10.1016/S0095-4543(05)70183-4.
59. Lushniak, B. D. (2004). Occupational contact dermatitis. Dermatol. Ther. 17, 272-277. doi: 10.1111/j.1396-0296.2004.04032.x.
60. Markets and Markets. (2014). Epoxy Resin Market by Application (Coatings, Electronics, Construction, Wind Turbine, Composites and Adhesives) and Geography-Trends and Forecast to 2019. Available at: http://www.marketsandmarkets.com/PressReleases/epoxy-resins.asp [accessed February 18, 2015].
61. McKim, J. M., Keller, D. J., and Gorski, J. R. (2012). An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing. Cutan. Ocul. Toxicol. 31, 292-305. doi: 10.3109/15569527.2012.667031.
62. Mehling, A., Eriksson, T., Eltze, T., Kolle, S., Ramirez, T., Teubner, W., et al. (2012). Non-animal test methods for predicting skin sensitization potentials. Arch. Toxicol. 86, 1273-1295. doi: 10.1007/s00204-012-0867-6.
63. Merckel, F., Bernard, G., Mutschler, J., Gimenez-Arnau, E., Gerberick, G. F., and Lepoittevin, J. P. (2010). Effect of a microemulsion dystem on hapten-peptide reactivity studies: examples of hydroxycitronellal and citral, fragrance skin sensitizers, with glutathione. Chem. Res. Toxicol. 23, 1433-1441. doi: 10.1021/Tx100043b.
64. Migdal, C., Botton, J., El Ali, Z., Azoury, M. E., Guldemann, J., Gimnez-Arnau, E., et al. (2013). Reactivity of chemical sensitizers toward amino acids in cellulo plays a role in the activation of the Nrf2-ARE pathway in human monocyte dendritic cells and the THP-1 cell line. Toxicol. Sci. 133, 259-274. doi: 10.1093/toxsci/kft075.
65. Mose, A. P., Lundov, M. D., Zachariae, C., Menne, T., Veien, N. K., Laurberg, G., et al. (2012). Occupational contact dermatitis in painters-an analysis of patch test data from the Danish Contact Dermatitis Group. Contact Dermatit. 67, 293-297. doi: 10.1111/j.1600-0536.2012.02074.x.
66. Natsch, A. (2010). The Nrf2-Keap1-ARE Toxicity pathway as a cellular sensor for skin sensitizers-functional relevance and a hypothesis on innate reactions to skin sensitizers. Toxicol. Sci. 113, 284-292. doi: 10.1093/toxsci/kfp228.
67. Natsch, A., Emter, R., and Ellis, G. (2009). Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing. Toxicol. Sci. 107, 106-121. doi: 10.1093/toxsci/kfn204.
68. Natsch, A., Emter, R., Gfeller, H., Haupt, T., and Ellis, G. (2014). Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment. Toxicol Sci. 145, 319. doi: 10.1093/toxsci/kfu229.
69. Natsch, A., Ryan, C. A., Foertsch, L., Emter, R., Jaworska, J., Gerberick, F., et al. (2013). A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J. Appl. Toxicol 33, 1337-1352. doi: 10.1002/jat.2868.
70. Niklasson, I. B., Broo, K., Jonsson, C., Luthman, K., and Karlberg, A. T. (2009). Reduced sensitizing capacity of epoxy resin systems: a structure-activity relationship study. Chem. Res. Toxicol. 22, 1787-1794. doi: 10.1021/Tx900193s.
71. Nixon, R., Cahill, J., and Jolanki, R. (2012). "Epoxy resins, "in Kanerva's Occupational Dermatology, eds T. Rustemeyer, P. Elsner, S.-M. John, and H. Maibach (Berlin: Springer-Heidelberg), 559-581. doi: 10.1007/978-3-642-02035-3_51.
72. Obach, R. S., and Kalgutkar, A. S. (2010). "Reactive electrophiles and metabolic activation, "in Comprehensive Toxicology, ed. C. A. McQueen (Oxford: Academic Press), 309-347.
73. O'Boyle, N. M., Delaine, T., Luthman, K., Natsch, A., and Karlberg, A. T. (2012). Analogues of the epoxy resin monomer diglycidyl ether of article bisphenol F: effects on contact allergenic potency and cytotoxicity. Chem. Res. Toxicol. 25, 2469-2478. doi: 10.1021/Tx300305k.
74. Organisation for Economic Co-operation and Development (OECD). (1998). "Harmonized integrated hazard classification system for human health and environmental effects of chemical substances, "in Proceedings of the 28th Joint Meeting of the Chemicals Committee and the Working Party on Chemicals. Paris: OECD. Available at: http://www.decd.sa.gov.au/docs/documents/1/ClassificationofHazardous [accessed Jan 24, 2013].
75. OECD. (2015). Test Guideline 442C-in Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA), OECD Guidelines for the Testing of Chemicals, Section 4. Paris: OECD Publishing. doi: 10.1787/9789264229709-en.
76. Ponten, A., Zimerson, E., and Bruze, M. (2009). Sensitizing capacity and cross-reactivity of phenyl glycidyl ether studied in the guinea-pig maximization test. Contact Dermat. 60, 79-84. doi: 10.1111/j.1600-0536.2008.01475.x.
77. Python, F., Goebel, C., and Aeby, P. (2007). Assessment of the U937 cell line for the detection of contact allergens. Toxicol. Appl. Pharm. 220, 113-124. doi: 10.1016/j.taap.2006.12.026.
78. Richter, A., Schmucker, S. S., Esser, P. R., Traska, V., Weber, V., Dietz, L., et al. (2013). Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC-IFN-gamma and TNF-alpha readout. Toxicol. In Vitro 27, 1180-1185. doi: 10.1016/j.tiv.2012.08.007.
79. Roberts, D. W., and Natsch, A. (2009). High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of michael acceptor electrophiles. Chem. Res. Toxicol. 22, 592-603. doi: 10.1021/Tx800431x.
80. Romyhr, O., Nyfors, A., Leira, H. L., and Smedbold, H. T. (2006). Allergic contact dermatitis caused by epoxy resin systems in industrial painters. Contact Dermat. 55, 167-172. doi: 10.1111/j.1600-0536.2006.00894.x.
81. Saito, K., Nukada, Y., Takenouchi, O., Miyazawa, M., Sakaguchi, H., and Nishiyama, N. (2013). Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis. Toxicol. In Vitro 27, 2213-2224. doi: 10.1016/j.tiv.2013.08.007.
82. Sakaguchi, H., Ashikaga, T., Miyazawa, M., Yoshida, Y., Ito, Y., Yoneyama, K., et al. (2006). Development of an in vitro skin sensitization test using human cell lines; human cell line activation test (h-CLAT) II. An inter-laboratory study of the h-CLAT. Toxicol. In Vitro 20, 774-784. doi: 10.1016/j.tiv.2005.10.014.
83. Schreiner, M., Peiser, M., Briechle, D., Stahlmann, R., Zuberbier, T., and Wanner, R. (2007). A loose-fit coculture of activated keratinocytes and dendritic cell-related cells for prediction of sensitizing potential. Allergy 62, 1419-1428. doi: 10.1111/j.1398-9995.2007.01511.x.
84. Schreiner, M., Peiser, M., Briechle, D., Stahlmann, R., Zuberbier, T., and Wanner, R. (2008). A new dendritic cell type suitable as sentinel of contact allergens. Toxicology 249, 146-152. doi: 10.1016/j.tox.2008.04.020.
85. Schwarzenberger, K., and Udey, M. C. (1996). Contact allergens and epidermal proinflammatory cytokines modulate langerhans cell E-cadherin expression in situ. J. Invest. Dermatol. 106, 553-558. doi: 10.1111/1523-1747.ep12344019.
86. Sonnenburg, A., Ahuja, V., Schreiner, M., Platzek, T., and Stahlmann, R. (2012). Assessment of the sensitizing potential of textile disperse dyes and some of their metabolites by the loose-fit coculture-based sensitization assay (LCSA). Arch. Toxicol. 86, 733-740. doi: 10.1007/s00204-012-0811-9.
87. Sosted, H. (2011). "Occupational contact dermatitis: hairdressers, "in Contact Dermat, 5th Edn, eds J. D. Johansen, P. J. Frosch, and J.-P. Lepoittevin (Berlin Heidelberg: Springer-Verlag), 865-871. doi: 10.1007/978-3-642-03827-3_45.
88. Spiewak, R. (2008). Patch testing for contact allergy and allergic contact dermatitis. Open Allergy J. 1, 42-51. doi: 10.2174/1874838400801010042.
89. Tapani, E., Taavitsainen, M., Lindros, K., Vehmas, T., and Lehtonen, E. (1996). Toxicity of ethanol in low concentrations-experimental evaluation in cell culture. Acta Radiol. 37, 923-926. doi: 10.3109/02841859609175470.
90. Thorgeirsson, A. (1978). Sensitization capacity of epoxy resin hardeners in the guinea pig. Acta Derm-Venereol. 58, 323-326.
91. Thorgeirsson, A., and Fregert, S. (1977). Allergenicity of epoxy resins in the guinea pig. Acta Derm-Venereol. 57, 253-256.
92. Toebak, M. J., Gibbs, S., Bruynzeel, D. P., Scheper, R. J., and Rustemeyer, T. (2009). Dendritic cells: biology of the skin. Contact Dermat. 60, 2-20. doi: 10.1111/j.1600-0536.2008.01443.x.
93. Troutman, J. A., Foertsch, L. M., Kern, P. S., Dai, H. J., Quijano, M., Dobson, R. L. M., et al. (2011). The incorporation of lysine into the peroxidase peptide reactivity assay for skin sensitization assessments. Toxicol. Sci. 122, 422-436. doi: 10.1093/toxsci/kfr101.
94. Uchino, T., Takezawa, T., Ikarashi, Y., and Nishimura, T. (2011). Development of an alternative test for skin sensitization using a three-demensional human skin model consisting of dendritic cells, keratinocytes and fibroblasts. Altern. Anim. Testing Ex. 16, 1-8. doi: 10.11232/aatex.16.1.
95. Urbisch, D., Mehling, A., Guth, K., Ramirez, T., Honarvar, N., Kolle, S., et al. (2014). Assessing skin sensitization hazard in mice and men using non-animal test methods. Regul. Toxicol. Pharmacol. doi: 10.1016/j.yrtph.2014.12.008.
96. Vocanson, M., Nicolas, J., and Basketter, D. (2013). In vitro approaches to the idenfication and characterization of skin sensitizers. Expert Rev. 8, 395-405. doi: 10.1586/17469872.2013.814882.
97. Vocanson, M., Achachi, A., Mutez, V., Cluzel-Tailhardat, M., Varlet, B. L., Rozieres, A., et al. (2014). "Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells, "in T Lymphocytes as Tools in Diagnostics and Immunotoxicology, Experientia Supplementum 104, ed. S. F. Martin (Basel: Springer), 89-100. doi: 10.1007/978-3-0348-0726-5_7.
98. Wanner, R., Sonnenburg, A., Quatchadze, M., Schreiner, M., Peiser, M., Zuberbier, T., et al. (2010). Classification of sensitizing and irritative potential in a combined in vitro assay. Toxicol. Appl. Pharm. 245, 211-218. doi: 10.1016/j.taap.2010.02.019.
99. Yoshida, Y., Sakaguchi, H., Ito, Y., Okuda, M., and Suzuki, H. (2003). Evaluation of the skin sensitization potential of chemicals using expression of co-stimulatory molecules, CD54 and CD86, on the naive THP-1 cell line. Toxicol. In Vitro 17, 221-228. doi: 10.1016/S0887-2333(03)00006-7.